Erste Asset Management Gmb H Bristol Myers Squibb CO Transaction History

Erste Asset Management Gmb H

$10.3 Trillion
Q3 2025

A detailed history of Erste Asset Management Gmb H transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Erste Asset Management Gmb H holds 82,617 shares of BMY stock, worth $3.87 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

82,617

Previous 318,201 74.04%

Holding current value

$3.87 Million

Previous $14.8 Billion 75.27%

% of portfolio

0.04%

Previous 0.12%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$43.31 - $48.98 $10.2 Million - $11.5 Million	-235,584 Reduced 74.04%	82,617 $3.65 Billion
Q2 2025 Aug 14, 2025	BUY	$44.12 - $59.6 $4.94 Million - $6.67 Million	111,924 Added 54.26%	318,201 $14.8 Billion
Q1 2025 May 14, 2025	BUY	$53.9 - $63.11 $2.38 Million - $2.78 Million	44,067 Added 27.17%	206,277 $12.3 Billion
Q4 2024 Feb 10, 2025	SELL	$51.92 - $59.94 $579,634 - $669,170	-11,164 Reduced 6.44%	162,210 $9.27 Billion
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $6.88 Million - $8.97 Million	173,374 New	173,374 $8.83 Billion

Q2 2024 Nov 26, 2024	BUY	$40.25 - $52.99 $262,953 - $346,183	6,533 Added 4.37%	155,877 $6.47 Billion
Q1 2024 Nov 26, 2024	BUY	$47.98 - $54.4 $19,287 - $21,868	402 Added 0.27%	149,344 $7.96 Billion
Q4 2023 Nov 26, 2024	BUY	$48.48 - $57.85 $232,607 - $277,564	4,798 Added 3.33%	148,942 $7.63 Billion
Q3 2023 Nov 26, 2024	SELL	$57.89 - $64.73 $7.13 Million - $7.98 Million	-123,237 Reduced 46.09%	144,144 $8.38 Billion
Q2 2023 Nov 26, 2024	SELL	$63.71 - $70.74 $5.34 Million - $5.93 Million	-83,801 Reduced 30.47%	191,195 $12.2 Billion
Q1 2023 Nov 26, 2024	SELL	$65.71 - $74.53 $395,902 - $449,043	-6,025 Reduced 2.14%	274,996 $18.8 Billion
Q4 2022 Nov 26, 2024	SELL	$68.48 - $81.09 $797,175 - $943,968	-11,641 Reduced 4.17%	267,381 $19.3 Billion
Q3 2022 Nov 26, 2024	BUY	$0.13 - $76.84 $13,994 - $8.27 Million	107,647 Added 62.09%	281,021 $20.1 Billion
Q2 2022 Nov 26, 2024	SELL	$72.62 - $79.98 $20.8 Million - $22.9 Million	-286,348 Reduced 50.65%	279,022 $21.8 Billion
Q1 2022 Nov 22, 2024	SELL	$61.48 - $73.72 $11.6 Million - $13.9 Million	-188,237 Reduced 21.42%	690,746 $50.5 Billion
Q4 2021 Nov 22, 2024	BUY	$53.63 - $62.52 $34.7 Million - $40.5 Million	647,551 Added 373.5%	820,925 $51.3 Billion
Q3 2021 Nov 22, 2024	BUY	$59.17 - $69.31 $1.73 Million - $2.03 Million	29,233 Added 3.44%	878,983 $52.2 Billion
Q2 2021 Nov 22, 2024	BUY	$61.91 - $67.42 $2.08 Million - $2.26 Million	33,556 Added 4.11%	849,750 $56.7 Billion
Q1 2021 Nov 22, 2024	BUY	$59.34 - $66.74 $5.29 Million - $5.95 Million	89,110 Added 12.26%	816,194 $51.5 Billion
Q4 2020 Nov 22, 2024	BUY	$57.74 - $65.43 $7.3 Million - $8.27 Million	126,403 Added 21.04%	727,084 $45 Billion
Q3 2020 Nov 22, 2024	BUY	$57.43 - $63.64 $24.5 Million - $27.2 Million	427,307 Added 246.47%	600,681 $36.2 Billion
Q2 2020 Nov 22, 2024	BUY	$54.82 - $64.09 $25.3 Million - $29.6 Million	461,300 Added 488.54%	555,724 $32.6 Billion
Q1 2020 Nov 22, 2024	SELL	$46.4 - $67.43 $20.5 Million - $29.8 Million	-441,546 Reduced 82.38%	94,424 $5.17 Billion
Q4 2019 Nov 22, 2024	BUY	$49.21 - $64.19 $17.8 Million - $23.3 Million	362,596 Added 209.14%	535,970 $34.2 Billion
Q3 2019 Nov 22, 2024	SELL	$42.77 - $50.71 $1.28 Million - $1.52 Million	-30,000 Reduced 5.17%	550,750 $27.9 Billion
Q2 2019 Nov 22, 2024	BUY	$44.62 - $49.34 $23.6 Million - $26.1 Million	529,100 Added 1024.39%	580,750 $26.3 Billion
Q1 2019 Nov 22, 2024	SELL	$45.12 - $53.8 $5.49 Million - $6.55 Million	-121,724 Reduced 70.21%	51,650 $2.46 Billion
Q4 2018 Nov 26, 2024	BUY	$48.76 - $63.23 $19.1 Million - $24.8 Million	391,996 Added 226.1%	565,370 $28.8 Billion

Others Institutions Holding BMY

# of Institutions

2,680

Shares Held

1.58B

Call Options Held

28.2M

Put Options Held

28.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.

Account

Erste Asset Management Gmb H Bristol Myers Squibb CO Transaction History